News
WID®-easy Test: Launched in Switzerland at the annual conference of the SGGG
Labor Team, the exclusive provider of the WID®-easy test in Switzerland, has launched the test with the support of Prof. Dr. Michael D. Mueller, President of the Swiss Society of Gynaecology and Obstetrics (SGGG), at its annual conference in Interlaken on June 28, 2024.
Data on cervical cancer test WID®-can published in Nature Medicine
The WID®-can test is referred to in the scientific literature as the WID-qCIN test and is an epigenetic test for the detection and prediction of cervical cancer.
New data from the EUTOPS team, working with Prof. Joakim Dillner and his team from the Karolinska Institute, has been published in Nature Medicine.
New publication in IJC – International Journal of Cancer
The study investigated whether different sampling methods influence the validity of the WID®-easy test (“WID-qEC test” in the scientific literature)
“AGO-Young Scientist Award” for Dr Chiara Herzog
Dr Chiara Herzog was honored with the “AGO – Young Scientist Award” for the scientific basis of the WID®-easy Test
High-throughput analytics for the WID®-easy test
Martin Widschwendter's research team has developed the non-invasive methylation-based diagnostic WID®-easy test for the early detection of endometrial cancer based on quantitative real-time PCR that can be implemented in diagnostic high-throughput laboratory...
90 % less surgical diagnostic procedures with the WID®-easy test
A recent study published in T H E L A N C E T O n c o l o g y demonstrated the ability of the new WID®-easy test to render 90% of surgical diagnostic procedures, e.g., hysteroscopy and curettage, unnecessary in women with abnormal bleeding during or after menopause....